The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 21, 2022

Filed:

Sep. 08, 2017
Applicant:

The General Hospital Corporation, Boston, MA (US);

Inventors:

Mark C. Poznansky, Newton Center, MA (US);

Jeffrey A. Gelfand, Cambridge, MA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/15 (2015.01); A61P 35/00 (2006.01); A61K 39/00 (2006.01); A61K 45/06 (2006.01); C07K 14/47 (2006.01); C07K 16/30 (2006.01); C12N 5/0784 (2010.01);
U.S. Cl.
CPC ...
A61K 35/15 (2013.01); A61K 39/001168 (2018.08); A61K 45/06 (2013.01); A61P 35/00 (2018.01); C07K 14/47 (2013.01); C07K 16/3069 (2013.01); C12N 5/0639 (2013.01); A61K 2039/6043 (2013.01); A61K 2039/892 (2018.08); C07K 2319/30 (2013.01); C12N 2501/07 (2013.01); C12N 2501/998 (2013.01); C12N 2502/1121 (2013.01); C12N 2502/30 (2013.01);
Abstract

This disclosure is directed to methods of preparing dendritic cells or other CD40 bearing antigen-presenting cells and methods of treating cancer by using the dendritic cells or other antigen-presenting cells in combination with anti-chemorepellant agents. This disclosure is further directed to methods of preparing T cells and methods of treating cancer, by activated T cells optionally in combination with anti-chemorepellant agents. The antigen presenting cells of the disclosure are activated by incubation with cancer cells and fusion proteins. The T cells of the disclosures are activated by incubation with activated antigen-presenting cells that were activated by incubation with cancer cells and a fusion protein. In particular, the fusion protein comprises an antigen-binding domain, e.g., an antibody or antibody fragment, and a stress protein domain.


Find Patent Forward Citations

Loading…